当前位置:首页 / 外科主动脉瓣置换术与经导管主动脉瓣置换术治疗中重度主动脉瓣狭窄患者的疗效对比▲
论著 | 更新时间:2026-11-17
|
外科主动脉瓣置换术与经导管主动脉瓣置换术治疗中重度主动脉瓣狭窄患者的疗效对比▲
Surgical aortic valve replacement versus transcatheter aortic valve replacement in the treatment of patients with moderate to severe aortic valve stenosis: a comparison of efficacy

微创医学 页码:579-584

作者机构:广西壮族自治区人民医院1 超声科,2 信息质控科,广西南宁市 530021

基金信息:广西壮族自治区卫生健康委员会自筹经费科研课题(编号:Z20200501) *通信作者

DOI:10.11864/j.issn.1673.2026.05.06

  • 中文简介
  • 英文简介
  • 参考文献

目的 比较外科主动脉瓣置换术(SAVR)与经导管主动脉瓣置换术(TAVR)治疗中重度主动脉瓣狭窄患者的临床疗效。方法 回顾性分析120例中重度主动脉瓣狭窄患者的临床资料。将接受TAVR治疗的患者作为TAVR组,接受SAVR治疗的患者作为SAVR组,每组60例,比较两组手术时长、术中出血量、术后住院时间、术后住ICU时间以及瓣周漏、房室传导阻滞、术后切口愈合不良、肺部感染等常见并发症发生情况;于术前、术后1周、术后半年、术后1年采用超声心动图测量两组左心室舒张末期内径(LVEDD)、左心室收缩末期内径(LVESD)、室间隔厚度(IVST)、左心室后壁厚度(LVPWT)、左心室短轴缩短率(LVFS)、左心室射血分数(LVEF)与主动脉瓣峰值血流速度(Vmax)。结果 TAVR组手术时长、术后住院时间、术后住ICU时间短于SAVR组,术中出血量少于SAVR组(P<0.05)。两组术后各时间点LVEDD、LVESD、IVST、LVPWT、Vmax较术前降低,LVEF、LVFS较术前升高(P<0.05),但术后1周、术后半年及术后1年,TAVR组IVST、LVPWT高于SAVR组(P<0.05)。TAVR组瓣周漏发生率高于SAVR组(P<0.05),两组其他并发症发生率差异无统计学意义(P>0.05)。结论  TAVR与SAVR在治疗中重度主动脉瓣狭窄中均表现出良好的疗效,其中TAVR创伤较小,术后恢复较快;对于高龄、基础状态欠佳或伴随多重合并症的患者,TAVR可能是较好的选择。但对于特定解剖结构(如二叶式主动脉瓣)的患者建议采用SAVR,临床上应根据患者情况,个性化选择合适的治疗方案。

Objective To compare the therapeutic efficacy of surgical aortic valve replacement (SAVR) and transcatheter aortic valve replacement (TAVR) in the treatment of patients with moderate to severe aortic valve stenosis. Methods A retrospective analysis was conducted on the clinical data of 120 patients with moderate to severe aortic valve stenosis. The patients who underwent TAVR were classified as the TAVR group, while those who underwent SAVR were classified as the SAVR group, with 60 cases in each group. The two groups were compared in terms of operative duration, intraoperative blood loss, postoperative hospital stay, postoperative ICU stay, as well as perivalvular leakage, atrioventricular block, common postoperative complications such as poor incision healing and pulmonary infection. Echocardiography was used to measure the left ventricular end-diastolic diameter (LVEDD), left ventricular end-systolic diameter (LVESD), interventricular septal thickness (IVST), left ventricular posterior wall thickness (LVPWT), left ventricular fractional shortening  (LVFS), left ventricular ejection fraction (LVEF), and peak aortic valve velocity (Vmax) in both groups before surgery, at 1 week postoperatively, 6 months postoperatively, and 1 year postoperatively. Results The operative duration, postoperative hospital stay and postoperative ICU stay in the TAVR group were shorter, and intraoperative blood loss was less than those in the SAVR group (P<0.05). LVEDD, LVESD, IVST, LVPWT and Vmax decreased while LVEF and LVFS increased at each postoperative time point in both groups compared with preoperative values (P<0.05). However, IVST and LVPWT in the TAVR group were higher than those in the SAVR group at 1 week, 6 months and 1 year after surgery (P<0.05). The incidence of paravalvular leak in the TAVR group was higher than that in the SAVR group (P<0.05). There was no statistically significant difference in the incidence of other complications between the two groups (P>0.05). Conclusion Both TAVR and SAVR achieve favorable efficacy in the treatment of patients with moderate to severe aortic valve stenosis, of which TAVR results in less surgical trauma and faster postoperative recovery. For elderly patients with poor baseline status or multiple comorbidities, TAVR may be the preferred option. However, SAVR is recommended for patients with specific anatomical features such as bicuspid aortic valve. Clinically, appropriate treatment regimens should be selected individually according to the patient's condition.

    无

1

浏览量

0

下载量

0

CSCD

工具集